
    
      This is a prospective, non-randomized, single-arm, multi-center, post-market clinical
      investigation designed to evaluate Abbott's Informity tool for Infinity DBS systems.

      This clinical investigation will be conducted at up to 5 centers in the United States.

      Up to 40 patients will be enrolled in the study. Of these subjects, up to 20 will have PD and
      up to 20 will have ET. All patients will have received Infinity DBS systems prior to
      enrolling in the study.

      Subjects participating in this clinical investigation will be followed for 6 months. The
      expected duration of enrollment is 6 months. The total duration of the clinical investigation
      is expected to be 18 months. The primary and secondary endpoints will be evaluated when all
      subjects have completed their 6 month follow-up visits
    
  